Lombard Odier Asset Management (Switzerland) Sa Halozyme Therapeutics, Inc. Transaction History

Lombard Odier Asset Management (Switzerland) Sa

$1.27 Billion
Q4 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$33.68 - $41.95 $5.89 Million - $7.34 Million	175,000 New	175,000 $7.12 Million
Q1 2023 May 15, 2023	SELL	$32.86 - $55.7 $7.88 Million - $13.4 Million	-239,744 Reduced 76.34%	74,304 $2.84 Million
Q4 2022 Feb 14, 2023	SELL	$40.06 - $59.44 $3.31 Million - $4.91 Million	-82,569 Reduced 20.82%	314,048 $17.9 Million
Q3 2022 Nov 14, 2022	SELL	$38.53 - $51.78 $955,004 - $1.28 Million	-24,786 Reduced 5.88%	396,617 $15.7 Million
Q2 2022 Aug 15, 2022	SELL	$37.35 - $48.3 $7.2 Million - $9.31 Million	-192,687 Reduced 31.38%	421,403 $18.5 Million
Q1 2022 May 16, 2022	BUY	$31.97 - $41.06 $19.6 Million - $25.2 Million	614,090 New	614,090 $24.5 Million
Q3 2021 Nov 12, 2021	SELL	$38.47 - $46.42 $11.5 Million - $13.9 Million	-300,000 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$38.84 - $51.31 $5.83 Million - $7.7 Million	-150,000 Reduced 33.33%	300,000 $13.6 Million
Q1 2021 May 17, 2021	SELL	$39.51 - $51.45 $790,200 - $1.03 Million	-20,000 Reduced 4.26%	450,000 $18.8 Million
Q4 2020 Feb 16, 2021	SELL	$25.81 - $43.62 $2.06 Million - $3.49 Million	-80,000 Reduced 14.55%	470,000 $20.1 Million
Q3 2020 Nov 16, 2020	SELL	$25.74 - $29.63 $2.06 Million - $2.37 Million	-80,000 Reduced 12.7%	550,000 $14.5 Million
Q2 2020 Aug 14, 2020	SELL	$16.25 - $26.81 $4.39 Million - $7.24 Million	-270,000 Reduced 30.0%	630,000 $16.9 Million
Q4 2019 Feb 14, 2020	BUY	$14.93 - $19.53 $8.96 Million - $11.7 Million	600,000 Added 200.0%	900,000 $16 Million
Q3 2019 Nov 14, 2019	SELL	$15.2 - $17.69 $3.8 Million - $4.42 Million	-250,000 Reduced 45.45%	300,000 $4.65 Million
Q2 2019 Aug 14, 2019	BUY	$14.75 - $17.26 $8.11 Million - $9.49 Million	550,000 New	550,000 $9.45 Million
Q4 2018 Feb 14, 2019	SELL	$13.33 - $18.66 $6.67 Million - $9.33 Million	-500,000 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$16.68 - $18.41 $8.34 Million - $9.21 Million	500,000 New	500,000 $9.09 Million
Q1 2018 May 15, 2018	SELL	$17.06 - $21.2 $5.54 Million - $6.88 Million	-324,500 Closed	0 $0
Q4 2017 Feb 13, 2018	BUY	$16.75 - $20.8 $2.09 Million - $2.59 Million	124,500 Added 62.25%	324,500 $6.57 Million
Q3 2017 Nov 14, 2017	BUY	$11.76 - $17.4 $2.35 Million - $3.48 Million	200,000	200,000 $3.47 Million

Others Institutions Holding HALO

# of Institutions

550

Shares Held

124M

Call Options Held

668K

Put Options Held

259K

Black Rock Inc. New York, NY

17.6M
Shares

$1.06 Billion
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

13.3M
Shares

$799 Million
0.01% of portfolio
State Street Corp Boston, MA

7.18M
Shares

$432 Million
0.01% of portfolio
Snyder Capital Management L P San Francisco, CA

4.17M
Shares

$251 Million
4.34% of portfolio
Bank Of America Corp Charlotte, NC

3.45M
Shares

$207 Million
0.01% of portfolio

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $8.38B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lombard Odier Asset Management (Switzerland) Sa, based on Form 13F filings with the SEC.

News

Stay updated on Lombard Odier Asset Management (Switzerland) Sa with notifications on news.

Account